07 January 2019
Modest Rise in Healthcare Deals Despite Uncertainty
Dealmaking in the healthcare sector dropped 5% in 2018, to USD 308 billion, as political uncertainty and new regulations came into force.
Read More

Healthcare is one of the largest, fastest growing industries in the world. It's also the most regulated, with rapidly changing rules and regulations that often conflict from one country to another. Healthcare companies face trying to understand how these laws impact their market and M&A strategies while contending with rising R&D costs, loss of patent protection of blockbuster drugs, pricing pressures, and competition from generics. Rapid convergence of the healthcare and technology sectors requires even more legal expertise given the additional data privacy and intellectual property concerns.

  • Ranked in the Top 10 Law Firms in the world for Life Sciences, Chambers Global
  • Ranked Band 1 for Life Sciences, Chambers Asia Pacific 2014-2018
  • Medical Law Firm of the Year, ALB Southeast Asia Awards 2017
  • Most Innovative Use of Technology for the Pharma MapApp, FT Most Innovative Lawyer Awards, 2015
  • No. 1 Healthcare M&A firm by deal volume for past three years, Thomson Reuters 2017
  • No. 1 Healthcare M&A firm by cross-border deal volume for past five years, Thomson Reuters 2017